Cargando…
Co‐delivery of dendritic cell vaccine and anti‐PD‐1 antibody with cryomicroneedles for combinational immunotherapy
Combinational immunotherapy of dendritic cell (DC) vaccines and anti‐programmed cell death protein 1 antibodies (aPD1) has been regarded as a promising strategy for cancer treatment because it not only induces tumor‐specific T cell immune responses, but also prevents failure of T cell functions by t...
Autores principales: | Chang, Hao, Wen, Xueyu, Li, Zhiming, Ling, Zhixin, Zheng, Yanting, Xu, Chenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487323/ https://www.ncbi.nlm.nih.gov/pubmed/37693072 http://dx.doi.org/10.1002/btm2.10457 |
Ejemplares similares
-
Ocular Delivery of Predatory Bacteria with Cryomicroneedles Against Eye Infection
por: Cui, Mingyue, et al.
Publicado: (2021) -
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
por: Zhu, Ping, et al.
Publicado: (2023) -
Delivery of healthcare and healthcare education in the digital era and beyond: opportunities and considerations
por: Chung, Seon Yoon
Publicado: (2023) -
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
por: Fu, Yuyin, et al.
Publicado: (2021) -
Advanced technologies for biomedical applications by emerging researchers in Asia‐Pacific
por: Wang, Weiping, et al.
Publicado: (2023)